DOCSLIB.ORG

Abo Grouping 60 (P) Abslut Cd4 & Cd8 Ct W/Rato

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Abo Grouping 60 (P) Abslut Cd4 & Cd8 Ct W/Rato Procedure description Charge (P) METHODONE 80 (P) ABO 60 (P) ABO GROUPING 60 (P) ABSLUT CD4 & CD8 CT W/RATO 140 (P) ACHR BINDING AB 148 (P) ACHR BLOCKING AB 148 (P) ADH 131 (P) AEROBIC CULTURE 132 (P) ALBUMIN, SERUM 56 (P) AMPHETAMINES 8 (P) AMPHETAMINES 80 (P) ANA 36 (P) ANTI - SSA 143 (P) ANTI - SSB 143 (P) ANTI CENTROMERE B 39 (P) ANTI CHROMATIN AB 35 (P) ANTI DS DNA 41 (P) ANTI HISTONE 39 (P) ANTI Jo-1 39 (P) ANTI RNP 39 (P) ANTI RNP SLP AB 39 (P) ANTI Scl-70 39 (P) ANTI SM 39 (P) ANTI SM SLP AB 39 (P) ANTI-DNA (DS) Ab Qn 41 (P) ANTI-GROUP B STREPTOCOCCUS 104 (P) ANTI-H INFLUENZA TYPE B 104 (P) ANTI-N MENINGITIS A/Y 104 (P) ANTI-N MENINGITIS C/W 135 104 (P) ANTI-STREP PNEUMONIA 104 (P) ANTI-THYROGLOBULIN AB 194 (P) ANTI-THYROID MICROSOMAL AB 192 (P) ANTIBODY SCREEN 109 (P) ANTICARDIOLYPIN AB IGA 58 (P) ANTICARDIOLYPIN AB IGG 58 (P) ANTICARDIOLYPIN AB IGM 58 (P) ANTIGEN TYPING,C 74 (P) ANTIGEN TYPING,c 74 (P) ANTIGEN TYPING,E 74 (P) ANTIGEN TYPING,e 74 (P) ANTIGEN TYPING,M 74 (P) ANTIGEN TYPING,N 74 (P) ANTIGEN TYPING,S 74 (P) ANTIGEN TYPING,s 74 (P) ARSENIC, BLOOD 87 (P) ARSENIC, URINE 90 (P) B. HENSELAE IGG 55 (P) B. HENSELAE IGM 55 (P) B. QUINTANA IGG 55 (P) B. QUINTANA IGM 55 (P) BARBITURATES 8 (P) BARBITURATES 80 (P) BEEF 52 (P) BENZODIAZEPINES 8 (P) BENZODIAZEPINES 80 (P) BETA 2 GLYCO IGA 65 (P) BETA 2 GLYCO IGG 65 (P) BETA 2 GLYCO IGM 65 (P) BLEEDING TIME, IVY 52 (P) BLOOD GASES 158 (P) BONE MARROW/BLOOD CULTURE 480 (P) Bordetella pertussis DNA 90 (P) BRUCELLA ABORTUS 70 (P) BRUCELLA IGG 39 (P) BRUCELLA IGM 39 (P) BUFFY COAT PREP 70 (P) BV A. vaginae 119 (P) BV Megaspaera 119 (P) BVAB-2 119 (P) C-ANCA, CYTOPLASMIC 102 (P) CADMIUM, BLOOD 82 (P) CALIFORNIA ENCEPH IGG CSF 96 (P) CALIFORNIA ENCEPH IGG SER 96 (P) CALIFORNIA ENCEPH IGM CSF 96 (P) CALIFORNIA ENCEPH IGM SER 96 (P) Candida albicans 173 (P) Candida glabrata 173 (P) CARDIOLYPIN AB, IGA 171 (P) CARDIOLYPIN AB, IGG 171 (P) CARDIOLYPIN AB, IGM 171 (P) CCP IGA/IGG 72 (P) CD10 202 (P) CD103 202 (P) CD13 202 (P) CD14 202 (P) CD19 202 (P) CD20 202 (P) CD23 202 (P) CD33 202 (P) CD34 202 (P) CD38 202 (P) CD41 202 (P) CD45 202 (P) CD5 202 (P) CD7 202 (P) CD79B 267 (P) Chalmydia pneumo DNA 150 (P) CHLAMYDIA NAA 135 (P) CHLAMYDIA PROBE 110 (P) CHOCOLATE 52 (P) CK-MB 167 (P) CMV IGG 56 (P) COCAINE 8 (P) COCAINE 80 (P) COMPLETE BLOOD COUNT/DIFF 122 (P) CORN 52 (P) CORTISOL - 60 MINUTE 185 (P) CORTISOL-30 MINUTE 185 (P) CORTISOL-BASELINE 185 (P) CPK, TOTAL 82 (P) CREATININE, RANDOM URINE 44 (P) CREATININE, URINE 43 (P) CREATININE, URINE 72 (P) CROSSMATCH 124 (P) CRP 68 (P) CULTURE, AEROBIC 159 (P) CULTURE, AFB 167 (P) CULTURE, AFB 167 (P) CULTURE, ANAEROBIC 113 (P) CULTURE, BLOOD 128 (P) CULTURE, FUNGUS 150 (P) CULTURE,FUNGUS 150 (P) CULTURE,STOOL OR RECTL SWB 166 (P) EAST EQUINE ENCEPH IGG CSF 96 (P) EAST EQUINE ENCEPH IGG SER 96 (P) EAST EQUINE ENCEPH IGM CSF 96 (P) EAST EQUINE ENCEPH IGM SER 96 (P) EBV-CA, IgG 66 (P) EBV-CA, IgM 66 (P) EBV-EA 66 (P) EBV-NA 66 (P) EGG, WHOLE 52 (P) ENDOMYSIAL IGA 189 (P) ESR 38 (P) ESTRADIOL 133 (P) ESTRADIOL, FREE 100 (P) ESTRADIOL, SERUM 127 (P) ESTRADIOL, TOTAL 151 (P) ESTROGENS, SERUM 152 (P) FETAL MTRNL HEMMORAGE SCRN 88 (P) FIBRINOGEN, QUANTITATIVE 90 (P) FISH/SHELL MIX 52 (P) FLOW CYTOM, EA CELL SURF 1 96 (P) FLOW CYTOM,EA CELL SURF 2 96 (P) FLOW CYTOM,EA CELL SURF 3 96 (P) FREE KAPPA LIGHT CHAINS 99 (P) FREE LAMBDA LIGHT CHAINS 99 (P) FSH 115 (P) GASTRIN 168 (P) GC GONOCOCCUS NAA 135 (P) GC PROBE 183 (P) GLIADIN AB IGA 206 (P) GLIADIN AB IGG 206 (P) GLU/LACTOSE TOL SPEC # 1-3 122 (P) GLU/LACTOSE TOL SPEC # 4 39 (P) GLU/LACTOSE TOL SPEC # 5 39 (P) GLU/LACTOSE TOL SPEC # 6 39 (P) GLU/LACTOSE TOL SPEC # 7 39 (P) GLU/LACTOSE TOL SPEC # 8 39 (P) GN BROTH 47 (P) GRAM STAIN 36 (P) GROWTH HORMONE, SPEC #1 50 (P) GROWTH HORMONE, SPEC #2 50 (P) GROWTH HORMONE, SPEC #3 50 (P) GROWTH HORMONE, SPEC #4 50 (P) GROWTH HORMONE, SPEC #5 50 (P) GROWTH HORMONE, SPEC #6 50 (P) H PYLORI EVALUATION, IgA 126 (P) H PYLORI EVALUATION, IgG 126 (P) H PYLORI EVALUATION, IgM 126 (P) HEMATOCRIT 38 (P) HEMOGLOBIN 39 (P) HERPES I/II IGG 56 (P) HSV I IGG 63 (P) HSV I IGM 80 (P) HSV I NAA 207 (P) HSV II IGG 94 (P) HSV II IGM 119 (P) HSV II NAA 207 (P) HSV TYPE I, PCR 179 (P) HSV TYPE II, PCR 179 (P) IFE (SERUM) 195 (P) IGA 58 (P) IMMUNOGLOBULIN A (IgA) 68 (P) IMMUNOGLOBULIN E (IgE) 68 (P) IMMUNOGLOBULIN G (IgG) 68 (P) IMMUNOGLOBULIN IgG1 67 (P) IMMUNOGLOBULIN IgG2 67 (P) IMMUNOGLOBULIN IgG3 67 (P) IMMUNOGLOBULIN IgG4 67 (P) IMMUNOGLOBULIN M (IgM) 68 (P) INHIBIN A 103 (P) INSULIN 2 HOUR 61 (P) INSULIN FASTING 61 (P) INSULIN HALF HOUR 61 (P) INSULIN HOUR 61 (P) INSULIN, FREE 83 (P) INSULIN, TOTAL 61 (P) INTRINSIC FACTOR BLCKNG AB 174 (P) KAPPA MARKER 202 (P) KARYOTYPE ADDITIONAL 255 (P) LAMBDA MARKER 202 (P) LDH, TOTAL 77 (P) LEAD, BLOOD 68 (P) LEAD, URINE 90 (P) LIPID 159 (P) LYMPHOCYTE CULTURE 411 (P) MEASLES (RUBEOLA) 40 (P) MERCURY, BLOOD 81 (P) MERCURY, URINE 90 (P) METHYLMALONIC ACID 212 (P) MILK (COW 52 (P) MUMPS 40 (P) MYCOPLASMA IGG 215 (P) MYCOPLASMA IGM 215 (P) Mycoplasma pneumo DNA 150 (P) NMR PROFILE 131 (P) OPIATES 8 (P) OPIATES (MORPHINE) 80 (P) OSMOLALITY 29 (P) P-ANCA, PERINUCLEAR 102 (P) PARTIAL THROMBOPLASTN TIME 76 (P) PARVOVIRUS B19, IGG 106 (P) PARVOVIRUS B19, IGM 106 (P) PCP 80 (P) PE (SERUM) 131 (P) PEANUT 52 (P) PHENCYCLIDINE 80 (P) PLATELET COUNT 56 (P) PORK 52 (P) PROG 206 (P) PROGESTERONE, FREE 100 (P) PROGESTERONE, TOTAL 171 (P) PROTEIN, SERUM 71 (P) PROTEIN, URINE 47 (P) PROTEUS OX19 70 (P) PROTEUS OX2 70 (P) PROTEUS OXK 70 (P) PROTHROMBIN TIME 63 (P) PSAD 166 (P) Respiratory Virus Panel DN 810 (P) RF 49 (P) RH 60 (P) Rh (D) TYPING 60 (P) RHEUMATOID FACTOR 30 (P) RICKETTSIA RICKETTSIAE IGG 55 (P) RICKETTSIA RICKETTSIAE IGM 55 (P) RICKETTSIA TYPHI IGG 55 (P) RICKETTSIA TYPHI IGM 55 (P) RNP ANTIBODIES 39 (P) RUBELLA 33 (P) RUBELLA IGG 47 (P) SALMONELLA H GROUP a 70 (P) SALMONELLA H GROUP b 70 (P) SALMONELLA H GROUP d 70 (P) SALMONELLA O GROUP D 70 (P) SEROTYPE 1 33 (P) SEROTYPE 12 33 (P) SEROTYPE 14 33 (P) SEROTYPE 17 33 (P) SEROTYPE 19 33 (P) SEROTYPE 2 33 (P) SEROTYPE 20 33 (P) SEROTYPE 22 33 (P) SEROTYPE 23 33 (P) SEROTYPE 26 33 (P) SEROTYPE 3 33 (P) SEROTYPE 34 33 (P) SEROTYPE 4 33 (P) SEROTYPE 43 33 (P) SEROTYPE 5 33 (P) SEROTYPE 51 33 (P) SEROTYPE 54 33 (P) SEROTYPE 56 33 (P) SEROTYPE 57 33 (P) SEROTYPE 68 33 (P) SEROTYPE 70 33 (P) SEROTYPE 8 33 (P) SEROTYPE 9 33 (P) SHBG 150 (P) SHIGA TOXIN 1 95 (P) SHIGA TOXIN 2 95 (P) SJOGREN'S ANTI-SS-A 39 (P) SJOGREN'S ANTI-SS-B 39 (P) SMEAR, AFB 88 (P) SMEAR, AFB 88 (P) SMEAR, FUNGUS 66 (P) SMEAR, FUNGUS 66 (P) SMITH ANTIBODIES 39 (P) SOYBEAN 52 (P) ST LOUIS ENCEPH IGG CSF 96 (P) ST LOUIS ENCEPH IGG SER 96 (P) ST LOUIS ENCEPH IGM CSF 96 (P) ST LOUIS ENCEPH IGM SER 96 (P) STOOL, CAMPYLOBACTER 45 (P) T CELLS, TOTAL COUNT 113 (P) T3 FREE 104 (P) T4 80 (P) TCBC 11 (P) TCP7 12 (P) TDT 202 (P) TESTFREE 184 (P) TESTOSTERONE 127 (P) TESTOSTERONE, FREE 260 (P) TESTOSTERONE, TOTAL 130 (P) THC 8 (P) THC 80 (P) Thyroglobulin 125 (P) Thyroglobulin AB 93 (P) TISSUE CULTURE 495 (P) TISSUE TRANS IGA 113 (P) TLIPID 16 (P) TLIVER 11 (P) TOXOPLASMA IGG 62 (P) TPO AB 54 (P) TRICH NAA 135 (P) TROPONIN I 171 (P) TSH 123 (P) TTSH 23 (P) VIT B12 74 (P) VIT D 25 OH 138 (P) VITAMIN B12 174 (P) WEST EQUINE ENCEPH IGG CSF 96 (P) WEST EQUINE ENCEPH IGG SER 96 (P) WEST EQUINE ENCEPH IGM CSF 96 (P) WEST EQUINE ENCEPH IGM SER 96 (P) WEST NILE CSF, IGG 152 (P) WEST NILE CSF, IGM 152 (P) WEST NILE IGG CSF 102 (P) WEST NILE IGM CSF 101 (P) WEST NILE SERUM, IGM 152 (P) WHEAT 52 (P)ALDOSTERONE 189 (P)ALPHA FETO-PROTEIN (MATRNL) 183 (P)ANAEROBIC CULTURE 87 (P)ANTI-MENINGITIS B/E,COLI K1 104 (P)BETA HCG, SERUM, QUANTATIVE 223 (P)BILIRUBIN, NEONATAL DIRECT 54 (P)BILIRUBIN, NEONATAL, TOTAL 54 (P)ESTRIOL (PLACENTAL), SERUM 159 (P)IMMUNOFIXATION ELECT 195 (P)IMMUNOFIXATION ELECT 195 (P)PROTEIN ELECTROPHERESIS 131 (P)PROTEIN ELECTROPHORESIS 131 (P)RENIN 103 (P)WEST NILE SERUM, IGG 152 *NON COVERED PVT.ROOM PORTION 58 *NON COVERED PVT.ROOM PORTION 58 #NAME? 391 +PHYSC ADD'L 30 MIN (ADD ON) 230 +PHYSC ADD'L 45 MIN (ADD ON) 333 +PHYSC ADD'L 60 MIN (ADD ON) 475 .45% NS 1000cc 147 .45% NS 100cc 10 .45% NS 250cc 21 .45% NS 500cc 103 .9 NS 1000cc (1 LITER) 135 .9 NS 150cc 97 .9 NS 250 97 .9 NS 500cc (HALF LITER) 97 .9% NS 1000cc 147 .9% NS 100cc 83 .9% NS 150cc 83 .9% NS 250cc 83 .9% NS 500cc 83 .9% NS 50cc 83 .9% SALINE 1000 CC 7 0.45% NACL WITH 20 mEq KCl 34 0.45% NCAL 1000 ML (045 NS) 43 0.9% NaCl W/20 mEq KCL 37 0.9% NaCl W/40 mEq KCL 39 0.9% NS 1000cc 29 0.9% NS 100cc 14 02.107.102 PLATE 2.7/3.5MM 1521 02.118.520 SCREW 2.7 SELFTAP 116 02.211.034 SCREW 2.7 SELFTAP 280 0N07A GORE SUTURE TH-50 12/BX 63 0U01A SUTURE GORE THX-36 12/BX 63 1.3 CORTEX SCREW 209 1.35MM GUIDE WIRE DUAL TROCAR 284 1.5 7MM SCREW 400.807.96 115 1.5 9MM SCREW 400.809.96 109 1.5 10MM SCREW 400.810.96 109 1.5 12MM SCREW 400.812.96 109 1.5 13MM SCREW 400.813.96 109 1.5 14MM SCREW 400.814.96 109 1.5 16MM SCREW 400.816.96 109 1.5 18MM SCREW 400.818.96 109 1.5 20MM SCREW 400.820.96 109 1.5 22MM SCREW 400.822.96 109 1.5 24MM SCREW 400.824.96 109 1.5 DRILL BIT 310.507 336 1.5 PLATE 11 HOLE (T) 446.612 366 1.5 PLATE 12 HOLE (T) 446.234 366 1.5 PLATE 11 HOLE 446.233 366 1.5 PLATE 12 HOLE 446.032 397 1.5 PLATE 6 HOLE 446.031 366 1.5 PLATE CONDYLAR LT 446.63 469 1.5 PLATE LEFT 446.483 366 1.5 PLATE RIGHT 446.482 366 1.5 PLATE RT CONDYLAR 446.64 469 1.5 SCREW 11MM 400.811.96 109 1.5 SCREW 6MM 400.806.96 109 1.5 SCREW 8MM 400.808.96 109 1.5MM DRILL BIT 310.141 511 1.8MM DRILL BIT 110MM 310.509 336 1/2 NS W/20KCL 2B1357X 11 10 cc OPTEFORM 3436 10% DEX 1000ML BAG 36 10% DEX 500cc
Load more

Recommended publications
  • Management of Specific Wounds
    7 Management of Specific Wounds Bite Wounds 174 Hygroma 234 Burns 183 Snakebite 239 Inhalation Injuries 195 Brown Recluse Spider Bites 240 Chemical Burns 196 Porcupine Quills 240 Electrical Injuries 197 Lower Extremity Shearing Wounds 243 Radiation Injuries 201 Plate 10: Pipe Insulation Protective Frostbite 204 Device: Elbow 248 Projectile Injuries 205 Plate 11: Pipe Insulation to Protect Explosive Munitions: Ballistic, the Greater Trochanter 250 Blast, and Thermal Injuries 227 Plate 12: Vacuum Drain Impalement Injuries 227 Management of Elbow Pressure Ulcers 228 Hygromas 252 Atlas of Small Animal Wound Management and Reconstructive Surgery, Fourth Edition. Michael M. Pavletic. © 2018 John Wiley & Sons, Inc. Published 2018 by John Wiley & Sons, Inc. Companion website: www.wiley.com/go/pavletic/atlas 173 174 Atlas of Small Animal Wound Management and Reconstructive Surgery BITE WOUNDS to the skin. Wounds may be covered by a thick hair coat and go unrecognized. The skin and underlying Introduction issues can be lacerated, stretched, crushed, and avulsed. Circulatory compromise from the division of vessels and compromise to collateral vascular channels can result in Bite wounds are among the most serious injuries seen in massive tissue necrosis. It may take several days before small animal practice, and can account for 10–15% of all the severity of tissue loss becomes evident. All bites veterinary trauma cases. The canine teeth are designed are considered contaminated wounds: the presence of for tissue penetration, the incisors for grasping, and the bacteria in the face of vascular compromise can precipi- molars/premolars for shearing tissue. The curved canine tate massive infection. teeth of large dogs are capable of deep penetration, whereas the smaller, straighter canine teeth of domestic cats can penetrate directly into tissues, leaving a rela- tively small cutaneous hole.
    [Show full text]
  • Reconstructive
    RECONSTRUCTIVE Muscle versus Nonmuscle Flaps in the Reconstruction of Chronic Osteomyelitis Defects Christopher J. Salgado, Background: Surgical treatment of chronic osteomyelitis requires aggressive M.D. debridement followed by wound coverage and obliteration of dead space with Samir Mardini, M.D. vascularized tissue. Controversy remains as to the effectiveness of different tissue Amir A. Jamali, M.D. types in achieving these goals and in the eradication of disease. Juan Ortiz, M.D. Methods: Chronic osteomyelitis was induced in 26 goat tibias using Staphylo- Raoul Gonzales, D.V.M., coccus aureus as an infecting inoculum. In a single stage, debridement followed Ph.D. by reconstruction using either a muscle flap (n ϭ 13) or a fasciocutaneous flap Hung-Chi Chen, M.D. (n ϭ 13) was performed. Flap donor sites were closed primarily and antibiotics El Paso, Texas; Kaohsiung, Taiwan; were given for 5 days postoperatively. Daily clinical evaluation for 1 year was and Sacramento, Calif. performed and monthly radiographs were obtained for 9 months and 1 year after the reconstruction. Results: Twenty-five flaps survived completely, and one nonmuscle flap under- went partial flap loss following a period of venous congestion. There were no postoperative complications in the muscle flap group. Two goats (15 percent) in the nonmuscle group developed superficial wounds in the immediate post- operative period that resolved with conservative management. No limbs had recurrent osteomyelitis wounds at 1 year of clinical follow-up examination. Radiographic evidence of osteomyelitis was present in two goats (15 percent) in the muscle group and one goat (8 percent) in the nonmuscle group.
    [Show full text]
  • (TECA) Surgery
    Audit of Total Ear Canal Ablation-Lateral Bulla Osteotomy Procedures Performed by One Surgeon Audit project lead: D G Bentley Subject/area of practice: Surgery/Dermatology Date: January 2nd 2018 Reasons for Audit: To determine how complication rate of this procedure, both short and long term, compare with that in recently published literature and to be sure this procedure should be still be offered in-house rather than being referred to a surgical specialist. Background Total Ear Canal Ablation-Lateral Bulla Osteotomy (TECA-LBO) procedures on dogs (and cats) have been performed by this surgeon since 1991 and since that time over 260 procedures have been performed. The surgeon also runs a dermatology service with special interest in ear disease and wishes to provide a complete service whereby cases that are beyond medical treatment can go to surgery without being referred to a specialist surgeon. Indications for TECA-LBO are “end stage otitis”, where there is chronic irreversible change to the ear canal, intractable ear infections particularly as a result of middle ear infection and changes in the vicinity of the tympanic membrane/lower horizontal ear canal, and tumours in the ear canal which cannot be dealt with either by Lateral Wall Resection or Vertical Canal Ablation. Also sometimes, due to financial reasons, a client may prefer surgery to lengthy courses of treatment, requiring several anaesthetics and ear flushings, with no guarantee of success at the outset. The surgeon first learnt the technique that was published in video format in the “In Practice” series around 1991. This involved the use of an osteotome to separate the ear canal from the bulla and also looking for the facial nerve and pulling it out of the way using penrose drain material.
    [Show full text]
  • 228 April 2003 Category 1
    Laparoscopica cantireflux Edward T Chory, MD Tracey A Ross, CST, MEd surgery astroesophageal Reflux The number of undiagnosed cases Disease (GERD) is a com- promises to be much higher based mon condition with a on the millions of heartburn suf- heavy economic impact. In ferers who take over-the- G a study published in the counter medications to treat May 2002 issue of Gastroenterol- their symptoms. GERD is also the ogy, researchers calculated that most expensive of the digestive GERD is one of the most preva- conditions with annual direct lent digestive diseases in America costs at $9.3 billion.1 with 19 million diagnosed cases.1 APRIL 2003 The Surgical Technologist 13 228 APRIL 2003 CATEGORY 1 Indirect costs, such as missed work and lower (painful swallowing), esophageal spasm, and productivity, would be almost impossible to more rarely GI bleeding (hematemesis or mele- measure accurately. However, companies and na). Tertiary symptoms are unrelated to the individuals are likely to feel the financial impact esophagus, such as reflux-induced asthma, in increased insurance premiums. For example, hoarseness and pharyngitis. Tertiary symptoms in 2002, the Wall Street Journal reported that the have increasingly been considered indications cost of proton pump inhibitors (PPIs) increased for antireflux surgery, and recent reports have General Motors’ health care budget for employ- documented excellent results, particularly for ees and retirees more than $55 million.2 reflux-induced asthma.11 With increasing experience in laparoscopic Traditionally, antireflux surgery was reserved antireflux surgery over the last 10 years, mor- for patients who did not respond to medical bidity has decreased, outcomes have improved therapy.
    [Show full text]
  • Answer Key Chapter 1
    Instructor's Guide AC210610: Basic CPT/HCPCS Exercises Page 1 of 101 Answer Key Chapter 1 Introduction to Clinical Coding 1.1: Self-Assessment Exercise 1. The patient is seen as an outpatient for a bilateral mammogram. CPT Code: 77055-50 Note that the description for code 77055 is for a unilateral (one side) mammogram. 77056 is the correct code for a bilateral mammogram. Use of modifier -50 for bilateral is not appropriate when CPT code descriptions differentiate between unilateral and bilateral. 2. Physician performs a closed manipulation of a medial malleolus fracture—left ankle. CPT Code: 27766-LT The code represents an open treatment of the fracture, but the physician performed a closed manipulation. Correct code: 27762-LT 3. Surgeon performs a cystourethroscopy with dilation of a urethral stricture. CPT Code: 52341 The documentation states that it was a urethral stricture, but the CPT code identifies treatment of ureteral stricture. Correct code: 52281 4. The operative report states that the physician performed Strabismus surgery, requiring resection of the medial rectus muscle. CPT Code: 67314 The CPT code selection is for resection of one vertical muscle, but the medial rectus muscle is horizontal. Correct code: 67311 5. The chiropractor documents that he performed osteopathic manipulation on the neck and back (lumbar/thoracic). CPT Code: 98925 Note in the paragraph before code 98925, the body regions are identified. The neck would be the cervical region; the thoracic and lumbar regions are identified separately. Therefore, three body regions are identified. Correct code: 98926 Instructor's Guide AC210610: Basic CPT/HCPCS Exercises Page 2 of 101 6.
    [Show full text]
  • Bone Forceps and Rongeurs
    Bone Forceps and Rongeurs Zepf Bone Forceps and Preferred by both neurosurgeons and Rongeurs have double action joints orthopaedic surgeons. that allow a surgeon to use one hand to cut bone with ease and precision. Unique shape of rongeurs allows for no blocking of the field of vision. Secured with screws which allows instrument to be sharpened or repaired Long history of genuine reliability. as needed. Page 10 Zepf Bone Forceps and Rongeurs 35-6401 PLIERS W/SIDE CUT, WIDE JAW 8. 35-6504 LEWIN BONE HOLDING FORCEPS 7” 35-6508-18 VERBRUGGE BONE HOLD. FORCEPS 7” 35-6513 LANE BONE HOLDING FORCEPS 13” 35-6544 FARABEUF BONE HOLDING FORCEPS 10” 35-6554 KLEINERT-KUTZ BONE CUTTING FORCEPS 6” 35-6562 LISTON BONE CUTTING FORCEPS STR 7.5” 35-6566 LISTON BONE CUTTING FORCEPS STR 10.5” 35-6567 LISTON BONE CUTTING FORCEPS ANGLED 10.75” 35-6570 KLEINERT-KUTZ BONE RONGEUR CRV 5.25” 35-6571 KLEINERT-KUTZ RONGEUR STRONG CRV 5.25” 35-6579-16 LEMPERT BONE RONGEUR CVD.6.25” 35-6579-19 LEMPERT BONE RONGEUR 7.5” 35-6583 BEYER BONE RONGEUR 7” 35-6587-15 KLEINERT-KUTZ BONE RONGEUR 6” 35-6587-18 KLEINERT-KUTZ BONE RONGEUR 7” 35-6590 BEYER BONE RONGEUR 7.25” STR. 35-6591 BEYER BONE RONGEUR 7.25” CVD. 35-6595 ZAUFAL-JANSEN BONE RONGEUR 7” CRV 35-6600 MARQUARDT BONE RONGEUR 8” CRV 35-6604 LUER BONE RONGEUR 8.75” STR. 35-6606 LUER BONE RONGEUR 8.75” curved 35-6610-1 LEKSELL BONE RONGEUR 9.5 SLY CRV WIDE 35-6610-2 LEKSELL BONE RONGEUR 9.5” SLY CRV NARROW 35-6612 STILLE-LUER DUCKBILL RONGEUR 9.5” 35-6612-1 LEKSELL BONE RONGEUR 9.5” WIDE 35-6612-2 LEKSELL BONE RONGEUR 9.5” NARROW 35-7956-3 SELVERSTONE LAMINECTOMY RONGEUR 6” 2X3MM 35-7956-5 SELVERSTONE LAMINECTOMY RONGEUR 6” 2X5MM 35-7960-4 SCHLESINGER LAMINECTOMY RONGEUR 6” 35-7964 CUSHING LAMINECTOMY RONGEUR 6” CRV UP 35-7983 FERRIS-SMITH LAMINECTOMY RONGEUR 7” STR 35-8004-2 SPURLING-KERRISON LAMINECTOMY PUNCH 7” 35-8008-5 SPURLING-KERRISON LAMINECTOMY PUNCH 7” SURGICAL INSTRUMENTS, INC.
    [Show full text]
  • Cardinal Health™ Jackson-Pratt® Wound Drain Offerings
    Cardinal Health™ Jackson-Pratt® Wound drain offerings Delivering confidence in product performance, with a commitment to patient comfort and safety. Cardinal Health™ Jackson-Pratt® The name you trust for wound drainage products. Nearly 50 A standardized years of A commitment portfolio to product legacy, to patient safety accommodate credibility and and comfort every need innovation What’s inside Introduction _____________________________ 3 Jackson-Pratt® Perforated Drains _________ 4-5 Jackson-Pratt® Channel Drains ____________ 6-7 Jackson-Pratt® Hemaduct® Wound Drains __________________________ 8-9 Cardinal Health™ Penrose Drains _________10 -11 Jackson-Pratt® Bulb Reservoirs and Accessories________________________12-13 Jackson-Pratt® 3-Spring Reservoirs and Accessories__________________________ 14 Argyle® Saratoga Drains __________________ 15 2 Cardinal Health™ Jackson-Pratt® Wound Drain catalog To order call: 800.227.3462 Cardinal Health™ Jackson-Pratt® Wound Drains Providing products to help improve patient safety and comfort is at the heart of what we do. For years, our quality, clinically designed Jackson-Pratt® Wound Drains have been supported with best practice guidance to help ensure that clinicians, too, feel comfortable and ultimately more confident in what they do. Our Jackson-Pratt® Wound Drain line, trusted amongst the clinical community since 1971 and a pillar of our extensive drainage offerings, represents our long- standing experience in the industry. You will find comfort in knowing that we provide a full assortment of wound drains and drainage systems, with an opportunity to standardize, ensuring that your wound drain portfolio will effectively meet the needs of a variety of situations and procedures. The Cardinal Health Wound Drain team is committed to helping provide solutions for more positive patient outcomes.
    [Show full text]
  • Applications in Spine Surgery and Surgical Technique Guide
    UltraSonic Bone Dissector: Applications in Spine Surgery and Surgical Technique Guide Peyman Pakzaban, MD, FAANS Houston MicroNeurosurgery - Houston, TX Abstract The Misonix BoneScalpel is a novel ultrasonic surgical device that cuts bone and spares soft tissues. This relative selectivity for bone ablation makes BoneScalpel ideally suited for spine applications where bone must be cut adjacent to dura and neural structures. Extensive clinical experience with this device confirms its safety and efficacy in spine surgery. The aim of this report is to describe BoneScalpel’s mechanism of action and the basis for its tissue selectivity, review the expanding clinical experience with BoneScalpel (including the author’s personal experience), and provide a few recommendations and recipes for en bloc bone removal with this revolutionary device. 1 Introduction Mechanism of Action The advent of ultrasonic bone dissection is as Ultrasound is a wave of mechanical energy significant to spine surgery today as the adoption of propagated through a medium such as air, water, or pneumatic drill was several decades ago. Power drills tissue at a specific frequency range. The frequency is liberated spine surgeons from the slow, repetitive, typically above 20,000 oscillations per second fatigue inducing, and occasionally dangerous (20 kHz) and exceeds the audible frequency range, maneuvers that are characteristic of manually hence the name ultrasound. In surgical applications, operated rongeurs. Now ultrasonic dissection with this ultrasonic energy is transferred from a blade to BoneScalpel empowers the surgeon to cut bone with tissue molecules, which begin to vibrate in response. an accuracy and safety that surpasses that of the Whether tissue molecules can tolerate this energy power drill.
    [Show full text]
  • Atlas of Surgical Techniques for the Upper Gastrointestinal Tract and Small Bowel
    Atlas of Surgical Techniques for the Upper Gastrointestinal Tract and Small Bowel A Volume in the Surgical Techniques Atlas Series Michael J. Rosen, MD Chief, Division of Gastrointestinal and General Surgery Director, Case Comprehensive Hernia Center Assistant Professor, Case Medical Center, University Hospitals of Cleveland, Cleveland, Ohio Jeffrey R. Ponsky, MD Chairman, Department of Surgery, Case Medical Center, University Hospitals of Cleveland, Cleveland, Ohio Series Editors: Courtney M. Townsend Jr., MD Professor and John Woods Harris Distinguished Chairman, Department of Surgery, The University of Texas Medical Branch, Galveston, Texas B. Mark Evers, MD Director, Lucille P. Markey Cancer Center Professor and Vice-Chair for Research, UK Department of Surgery, Markey Cancer Center Director Chair, Physician-in-Chief, Oncology Service Line, University of Kentucky, Markey Cancer Center, Lexington, Kentucky Copyright © 2010 by Saunders, an imprint of Elsevier Inc. Atlas of Surgical Techniques for the Upper GI Tract and Small Bowel - A Volume in the Surgical Techniques Atlas Series By Jeffrey Ponsky, MD and Michael Rosen, MD Key Features x Provides step-by-step guidance on a wide range of procedures, both open and interventional, giving you multiple options for approaching any challenge. x Examines the hottest topics in upper gastrointestinal and small bowel surgery. x Discusses pearls and pitfalls to help you avoid complications. x Presents more than 300 full-color illustrations and step-by-step intraoperative photographs for expert visual guidance. x Offers pre- and postoperative imaging studies that show the outcomes of various conditions following surgery. x Uses a consistent, easy-to-follow chapter format that includes clinical anatomy, pre-operative considerations, operative steps, post-operative care, and pearls and pitfalls to make reference easy.
    [Show full text]
  • Item Master CPT Code Charge 6090610 COMPREHENSIVE
    Item Number Item Description - Item Master CPT Code Charge 6090610 COMPREHENSIVE METABOLIC PANEL w/ Reflex- 80053 103.88 6202327 WIRE SYNT TIT KIRS TROC PT 1.25MM DIA 15 L8699 0 5387 NF-Premarin Oral Tablet 0.9MG 0 5398 NF-Falmina Tab 0.2MF-0.1MG 0 5517 NF-LaMICtal XR Extended Release Tab 100M 0 6130 NF-Nuedexta Oral Capsule 20MG-10MG 0 5992 NF-Terazosin HCl Oral Capsule 2MG 0 6203390 DRAIN 19 FR JACKSON-PRATT SU130-1325 0 5288 RXNF Minocycline HCl Capsule 50MG 0 5310 RXNF oxyMORphone HCl Tab ER 15MG 0 5388 RXNF aMILoride HCl Tablet 5MG 0 5564 NF- Felodipine Tablet ER 5MG 0 6213174 ANSPACH BURR 6MM FLUTED BALL MIA166B 298.36 8015007 SCREW SOF 4 X 11MM ZEPHIR C1713 1052.52 8025916 BIT 2.3 205.8 8026081 SA6AT5 CORRECTIVE LENS V2787 440 6200062 SUCTION IRRIGATOR SURGIFLEX 007200-903 0 5287 RXNF PARoxetine HCL Tab ER 25MG 0 6215042 SUTURE 3-0 VICRYL PS-2 J497G 0 6138 NF-Adderall XR Oral Cap ER 30MG 0 8015008 SCREW SOF 4 X 13MM ZEPHIR C1713 1052.52 5337 NF-Systane Ophth Solution 0 3774 RXNF Premarin Oral Tablet 0.9MG 0 6162 RXNF Chloroquine Phosphate Tablet 250 0 5756 RXNF Ziprasidone HCl Oral Capsule 20MG 0 8015009 SCREW SOF 4 X 15MM ZEPHIR C1713 1052.52 5427 RXNF Glyxambi Oral Tablet 25MG-5MG 0 8025918 BIT 2.5 205.8 5959 NF-EXCEDRIN EXTRA STRENGTH 250MG-250MG-6 0 5428 NF-Glyxambi Oral Tablet 25MG-5MG 0 5273 NF-Lansoprazole Oral Cap DR 30MG 0 5429 NF-Glyxambi Oral Tablet 25MG-5MG 0 8015391 WASHER TRI MED 180.2 5504 RXNF Movantik Oral Tablet 25MG 0 5336 RXNF Acebutolol HCl Capsule 200MG 0 2290384 erythromycin 0.5% ophth OINT 3.5 gm 0 5399 RXNF
    [Show full text]
  • Browne Deltoid Retractor
    Introduction Since 1826, physicians and Statement of Policy surgeons have depended on George Tiemann & Co., has manufactured fine surgical instruments since 1826. Since then, we have supplied the George Tiemann & Co. medical profession with high quality, correctly styled products. In addition to our own products, we represent other manufacturers and importers, and therefore welcome inquiries concerning instruments not shown in our catalog. While we feel that the patterns shown are the most widely used and accepted, occasionally another sytle may be preferred. In this event, we can usually supply the instrument if either a catalog number, sample or description can be provided. Returns for credit can be made without permission. However, this must be done within 30 days from date of billing. Items are subject to a restocking fee if they are not in original packaging material, or, have been autoclaved/sterilized. Instruments older than 30 days require approval and are also subject to restocking charges. When returning items, please provide the original invoice number, your order number (if any) and other pertinent information. Claims for shortages must be made within 5 days of package New surgical procedures, improved techniques, receipt. To avoid short shipments, all orders are computer refinements in tooling skills and advancements weighed and double checked for accuracy by two separate in metallurgy, emphasize the continuing need individuals. for change. We reserve the right to ship the most current models, which will always Ordering Information reflect the wishes of the medical profession. 1) Please use catalog number and supply size, style and quantity. Some catalog numbers cover more than one size or style.
    [Show full text]
  • Instruments 449-478 4/3/06 10:42 AM Page 449
    Instruments_449-478 4/3/06 10:42 AM Page 449 Neuro Hammers & Diagnostic ADC® NEUROLOGICAL HAMMERS Four of the most popular hammers for diagnosis of neurological function. 369110105375 Buck Hammer, 7 1/4˝, Chrome Plated Handle w/2 sided rubber head, Handle Conceals “screw-in” Brush, Needle Contained Within The Head 369310105374 Taylor Hammer, 7 1/2˝, Chrome Handle w/triangular rubber head, Orange 3693BK10141795 Taylor Hammer, 7 1/2˝, Chrome Handle w/triangular rubber head, Black 3693DG10141796 Taylor Hammer, 7 1/2˝, Chrome Handle w/triangular rubber head, Dark Green 3693RB10141797 Taylor Hammer, 7 1/2˝, Chrome Handle w/triangular rubber head, ADC® TUNING FORKS Royal Blue 369510105372 Wartenberg Pinwheel, 7 1/2˝, Stainless Steel Handle w/textured grip, Non magnetic, corrosion resistant aluminum alloy construction weighs 1/3 of Rotating Spur comparable steel tuning forks. Produced from 3/8˝ x 1˝ bar stock for superior 369710105373 Babinski Hammer, 8 1/2˝, Octagonal Stainless Steel Handle w/concealed performance and consistent frequency accuracy. Extra long 2˝ handle of turned needle, Rubber Head smooth aluminum to facilitate bone conduction tests. 50012810105366 Tuning Fork w/fixed weight, 128cps Frequency 50025610105367 Tuning Fork w/fixed weight, 256cps Frequency 50051210105368 Tuning Fork w/o weight, 512cps Frequency 50102410105369 Tuning Fork w/o weight, 1024cps Frequency 50204810105370 Tuning Fork w/o weight, 2048cps Frequency 50409610105371 Tuning Fork w/o weight, 4096cps Frequency 1-200 1-220 MILTEX HAMMERS 1-20010090643 Taylor Percussion
    [Show full text]